Overview

Dexmedetomidine Versus Triamcinolone Treatment of Carpal Tunnel Syndrome

Status:
Not yet recruiting

Trial end date:
2022-04-01

Target enrollment:
0

Participant gender:
All

Summary

Carpal tunnel syndrome (CTS) is a common mononeuropathy due to entrapment of the median nerve in the carpal tunnel. a lot of modaleties are available for treatment of mild to moderate CTS.

Phase:

N/A

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Assiut University

Treatments:

Dexmedetomidine
Triamcinolone

Criteria

Inclusion Criteria:

- adult patients

- complaining of carpal tunnel syndrome of 3 month duration or more

- diagnosed axonal neuropathy using electrodiagnosis , nerve conduction study

Exclusion Criteria:

- patient refusal

- infection at the site of intervention

- allergy to utilized drugs

- diabetic

- previous surgery in the site of injection

- previous injection in the targeted site within the last year